Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Theranos Quietly Settles Lawsuits With One of Its Biggest Investors May 1, 2017 Medtronic Snags Coverage for Micra Leadless Pacer January 26, 2017 Wait For It! Tapped Congressman to Become the Next 'Drug Czar' April 11, 2017
